| 10/6/2015 | CV | Theravance lowers conversion price of convertible notes due 2023
|
| 9/9/2015 | CV | Market Commentary: Dycom edges up in gray market; BroadSoft bringing new deal; Icahn bid for Vivus eyed
|
| 7/1/2015 | CV | Theravance lowers conversion price of convertible notes due 2023
|
| 2/23/2015 | CV | Market Commentary: Salix flat to lower in active trade after merger news; Spectrum sinks on patent ruling
|
| 12/23/2014 | CV | Theravance adjusts conversion rate of convertible notes due 2023
|
| 11/10/2014 | CV | Market Commentary: Dendreon drops after bankruptcy filing; Salix recoups some; Isis Pharmaceuticals on tap
|
| 6/17/2014 | CV | Theravance adjusts conversion rate of 2.125% convertibles due 2023
|
| 5/19/2014 | CV | Theravance to adjust conversion rate of 2.125% convertibles due 2023
|
| 12/31/2013 | CV | Outlook 2014: U.S. secondary market poised for continued strength, but investors eye Fed taper
|
| 10/25/2013 | CV | Market Commentary: NQ Mobile in focus after fraud allegations; Rayonier drops after earnings; AMR holds in
|
| 6/5/2013 | CV | Market Commentary: Array adds a point in busy debut; market weaker; DDR off 0.25 point; Prologis in 0.5 point
|
| 6/4/2013 | CVLM | Theravance to redeem $172.5 million 3% convertibles under soft call
|
| 5/20/2013 | CV | Market Commentary: Tesla dips below par in volatile action; Theravance eyed; AMR surges despite lower shares
|
| 5/13/2013 | CV | Market Commentary: Endo Health 'comes in' on FDA news; Theravance still trades mixed; Shutterfly on deck
|
| 5/10/2013 | CV | Market Commentary: Theravance mixed on COPD drug approval; Meritor improves; Electronic Arts extends gains
|
| 4/29/2013 | CV | Market Commentary: Auxilium 'comes in' on disappointing quarter; Cemex slips on earnings; Theravance in focus
|
| 4/26/2013 | CV | Market Commentary: New Supernus jumps outright, adds on hedge; Theravance contracts on hedge; D.R. Horton up
|
| 4/25/2013 | CV | Market Commentary: PennyMac adds to 101; planned Supernus eyed; Microsoft adds; Theravance to split company
|
| 4/18/2013 | CV | Market Commentary: Intelsat adds outright; Theravance bonds mixed; Boston Properties' called bonds in focus
|
| 3/8/2013 | CV | Market Commentary: Theravance gains on hedge; Radian finds its footing; Smithfield jumps on potential split
|
| 3/4/2013 | CV | Market Commentary: Theravance up outright, flat to higher on hedge; Radian adds; Forestar, Hanwha improve
|
| 1/23/2013 | CV | Market Commentary: Planned KB Home adds in gray; newer Theravance still weak; Molycorp, OPKO, Auxilium on tap
|
| 1/22/2013 | CV | Theravance greenshoe lifts convertibles due 2023 to $287.5 million
|
| 1/18/2013 | CV | Market Commentary: Holiday weekend results in subdued trading; Theravance, Solazyme new issues lackluster
|
| 1/18/2013 | CV | New Issue: Theravance sells $250 million 10-year convertibles at 2.125%, up 32.5%
|
| 1/17/2013 | CV | Market Commentary: New Pacira surges on debut; planned Theravance seen cheap; planned Solazyme lacks borrow
|
| 1/16/2013 | CV | Market Commentary: InterMune notches stellar debut; Pacira sees revised terms; Cobalt steady dollar neutral
|
| 1/16/2013 | CV | Theravance to price $250 million 10-year convertibles to yield 2%-2.5%, up 27.5%-32.5%
|
| 7/11/2012 | CV | Market Commentary: Patriot Coal convertibles busy; Kodak gains on executive bonus plan; Theravance firms up
|
| 7/3/2012 | CV | Market Commentary: Convertibles quiet ahead of holiday; Lincare, Theravance extend gains; U.S. Steel better
|
| 4/4/2012 | CV | Market Commentary: SanDisk 1.5% convertibles come in on hedge; NetApp trades in line; Western Refining adds
|
| 4/3/2012 | CV | Market Commentary: Intel, Xilinx active, weaker as broader market reacts to FOMC minutes; Theravance better
|
| 1/30/2012 | CV | Market Commentary: Amylin active; Theravance better bid; MF Global 'comes in'; RadioShack warns on earnings
|
| 1/10/2012 | CV | Market Commentary: PHH's existing convertibles steady to higher on new deal launch; Kodak paper improves
|
| 2/4/2011 | CV | Market Commentary: Jaguar Mining gains; Hovnanian slips below par; Clearwire up on spectrum-purchase chatter
|
| 10/15/2010 | CV | Market Commentary: EMC holds gains; Western Refining extends gains; EnerSys up; new Alon issue doesn't price
|
| 3/30/2010 | CV | Market Commentary: Concur draws modest enthusiasm; Theravance; Navistar, Annaly Capital better; Ford down
|
| 7/23/2009 | CVHY | Theravance files $200 million shelf registering debt, stock, warrants
|
| 1/23/2008 | CV | Theravance greenshoe exercised, lifts 3% convertibles to $172.5 million
|
| 1/17/2008 | CV | New Issue: Theravance prices $150 million 3% convertible subordinated notes due 2015, up 30%
|
| 1/17/2008 | CV | Market Commentary: Citi upsizes; WaMu moves lower ahead of earnings; Theravance opens quietly higher
|
| 1/16/2008 | CV | Market Commentary: Intel down on earnings; Pioneer opens flat on falling oil; Transocean down; Citigroup deal drawing high bids
|
| 1/15/2008 | CV | Market Commentary: Citigroup launches preferreds to help right ship; Pioneer on the way; UAL, Continental up on merger talk
|
| 1/15/2008 | CV | Theravance launches $150 million convertible notes due 2015; talked at 2.75%-3.25%, up 25%-30%
|
